Amsterdam

• Avelumab Short Maintenance Trial Pending
  2024-512975-11-01 11 urothelial cancer
• The Effect of Mitapivat on Cerebral Perfusion and Oxygen Metabolism in Sickle Cell Disease Pending
  2024-513528-41-02 5 Sickle cell anaemia
• Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to the Renal Pelvis (LUNAR) Pending
  2024-514360-70-00 9 Low-grade upper track urothelial carcinoma (LG-UTUC)
• GeranylGeranylAcetone as prevention for postoperative Atrial Fibrillation (GENIALITY) Pending
  2024-514743-28-00 4 Postoperative Atrial Fibrillation
• Ultrasound-guided Radiofrequency Ablation versus radioactive Iodine as treatment for Hyperthyroidism caused by Solitary Autonomous Thyroid N … Pending
  2024-515602-34-01 11 Hyperactive thyroid nodules
• Neoadjuvant AXITINIB plus AVELUMAB for patients with localized RCC and a moderate to high risk of recurrence Pending
  2024-515825-27-00 4 renal cell carcinoma
• Changes in the tumour microenvironment after intravenous or intradermal administration of anti-CTLA-4 in combination with anti-PD1 treatment … Pending
  2024-516545-39-01 9 unresectable stage III – IV melanoma
• EPITOME-1015-I: A phase I study to investigate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesop … Pending
  2024-516787-28-00 1 Epithelial Ovarian Carcinoma
• A trial to learn how safe AZD9750 is and how well it works in people with metastatic prostate cancer when given with or without other antica … Pending
  2024-516976-14-00 7 Metastatic Prostate Cancer
• Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases – a phase … Pending
  2024-517152-34-00 4 Irresectable peritoneal metastases of colorectal cancer
• ATLAS trial Pending
  2024-517233-40-00 6 Perianal abscess
• RESET-TRD; a Randomised trial on oral ESketamine compared to Electroconvulsive Therapy for patients with Treatment Resistant Depression Pending
  2024-517485-42-00 5 Non-psychotic therapy resistant unipolar depression
• Colchicine to inhibit atherosclerosis in patients with cancer receiving immune therapy Pending
  2024-518100-45-00 5 Atherosclerosis
• Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe … Pending
  2024-518420-80-00 5 Primary infection prophylaxis for secondary immunodeficiency (SID) in
• Chemo-immunotherapy before and after surgery for peritoneal metastases of large bowel cancer. Pending
  2024-518570-13-00 10 Resectable peritoneal metastases of a colorectal origin
• ESTIS trial: Early Stop of targeted Treatment in children with Systemic JIA. Pending
  2024-518684-35-00 6 autoimmune disorders, joint disorders synonym: Still's disease, system
• Anticoagulant medicines for Balloon Pulmonary Angioplasty Pending
  2024-518803-23-00 6 Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
• Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending
  2024-518821-13-00 4 Non-cystic Fibrosis Bronchiectasis
• Comparison of two treatments (intrathecal baclofen pump and selective dorsal rhizotomy) for children with cerebral palsy who cannot walk Pending
  2024-518822-33-01 6 Cerebral Palsy
• A trial to learn how safe durvalumab with chemotherapy is and how well it works in adults with muscle-invasive bladder cancer Pending
  2024-519246-75-01 4 Patients With Muscle-Invasive Bladder Cancer
• Weight-loss Effects aNd absorption of Direct oral anticoagulants in roux-en-Y gastric bypass patients: a prospective study (WENDY) Pending
  2024-519737-30-00 6 Roux-en-Y gastric bypass
• A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cel … Pending
  2024-519786-22-01 9 metastatic non-small cell lung cancer (NSCLC)
• Research on two creams (Monobenzon / Imiquimod) together with the standard treatment for advanced or metastatic melanoma (ImMI). Pending
  2024-520052-19-04 9 Malignant Melanoma
• An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending
  2024-520218-23-00 10 Pulmonary Arterial Hypertension

Showing 25–48 of 1,112 trials